Ask AI

CELMoDs in Myeloma—What’s Here, What’s Next, and What’s on the Horizon

Enhance your understanding of the mechanisms of action and differences in emerging CELMoDs used to manage multiple myeloma, and the clinical implications of achieving MRD negativity through a certified on-demand webcast, audio podcast, expert-authored ClinicalThought commentary, and downloadable slides.

Share

Program Content

Activities

CELMoDs for MM
CELMoD Clinical Trial Data in Multiple Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2025

Expires: November 29, 2025

MRD in MM
Use of MRD in Multiple Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2025

Expires: November 29, 2025

Protein Degradation in MM
Novel Approaches to Protein Degradation Pathways in Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2025

Expires: November 29, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb